Evaluation and treatment of infertile women with Asherman syndrome: an updated review focusing on the role of hysteroscopy.
Asherman’s syndrome
Hysteroscopy
Infertility
Intrauterine adhesions
Synechiae
Journal
Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
07
01
2020
revised:
03
03
2020
accepted:
27
03
2020
pubmed:
24
5
2020
medline:
16
6
2021
entrez:
24
5
2020
Statut:
ppublish
Résumé
Asherman syndrome is a rare acquired clinical condition resulting in the obliteration of the uterine cavity causedby the presence of partial or complete fibrous intrauterine adhesions involving at least two-thirds of the uterine cavity potentially obstructing the internal cervical orifice. Common reported symptoms of the disease are alterations of the menstrual pattern with decreased menstrual bleeding leading up to amenorrhoea and infertility. Hysteroscopy is currently considered the gold standard diagnostic and therapeutic approach for patients with intrauterine adhesions. An integrated approach, including preoperative, intraoperative and postoperative therapeutic measures, however, are warranted owing to the complexity of the syndrome. This review aims to summarize the most recent evidence on the recommended preoperative, intraoperative and postoperative procedures to restore the uterine cavity and a functional endometrium, as well as on the concomitant use of adjuvant therapies to achieve optimal fertility outcomes.
Identifiants
pubmed: 32444259
pii: S1472-6483(20)30176-0
doi: 10.1016/j.rbmo.2020.03.021
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
55-61Informations de copyright
Copyright © 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.